We are live on ! Find out more
BC

Bruce & Co Portfolio holdings

AUM $350M
1-Year Est. Return 33.5%
This Fund
S&P 500
This Quarter Est. Return
-5.29%
1 Year Est. Return
+33.5%
3 Year Est. Return
+65.72%
5 Year Est. Return
+73.85%
10 Year Est. Return
+249.08%
AUM
$293M
AUM Growth
-$63.1M
Cap. Flow
-$55.7M
Cap. Flow %
-18.99%
Top 10 Hldgs %
69.39%
Holding
39
New
2
Increased
1
Reduced
21
Closed
1

Top Buys

Rank Stock Value
1
DAR icon
Darling Ingredients
DAR
+$4.37M
2
VICR icon
Vicor
VICR
+$1.33M
3
IGMS
IGM Biosciences
IGMS
+$551K

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$8.59M
2
UHAL.B icon
U-Haul Holding Co Series N
UHAL.B
+$4.49M
3
DUK icon
Duke Energy
DUK
+$4.26M
4
ABBV icon
AbbVie
ABBV
+$4.22M
5
CMS icon
CMS Energy
CMS
+$3.52M

Sector Composition

Rank Sector Weight
1 Healthcare 34.02%
2 Utilities 28.11%
3 Industrials 15.07%
4 Communication Services 6.59%
5 Financials 6.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UHAL.B icon
1
U-Haul Holding Co Series N
UHAL.B
$12.2B
$29.2M 9.96%
557,700
-82,830
-13% -$4.49M
ABBV icon
2
AbbVie
ABBV
$450B
$24.3M 8.28%
163,000
-28,743
-15% -$4.22M
MRK icon
3
Merck
MRK
$315B
$22.7M 7.74%
220,700
-79,672
-27% -$8.59M
XEL icon
4
Xcel Energy
XEL
$49.2B
$19.6M 6.69%
343,000
-28,754
-8% -$1.73M
CMS icon
5
CMS Energy
CMS
$22.8B
$18.9M 6.44%
356,000
-60,755
-15% -$3.52M
DUK icon
6
Duke Energy
DUK
$97.5B
$18.9M 6.43%
213,890
-46,429
-18% -$4.26M
NEE icon
7
NextEra Energy
NEE
$185B
$18.5M 6.32%
323,600
-21,514
-6% -$1.49M
ALL icon
8
Allstate
ALL
$64.3B
$17.5M 5.97%
157,200
-9,644
-6% -$1.05M
PFE icon
9
Pfizer
PFE
$143B
$17.2M 5.87%
519,500
-19,126
-4% -$676K
T icon
10
AT&T
T
$152B
$16.7M 5.69%
1,111,000
-9,254
-0.8% -$136K
ABT icon
11
Abbott
ABT
$175B
$15.5M 5.28%
160,000
-6,843
-4% -$719K
IIIN icon
12
Insteel Industries
IIIN
$602M
$11.1M 3.8%
343,423
– –
BHC icon
13
Bausch Health
BHC
$1.8B
$6.99M 2.38%
850,000
-75,780
-8% -$653K
AAPL icon
14
Apple
AAPL
$4.9T
$6.9M 2.35%
40,300
-18,501
-31% -$3.39M
AVA icon
15
Avista
AVA
$3.45B
$6.52M 2.22%
201,500
-3,500
-2% -$125K
FOCL
16
EDAP TMS S.A.
FOCL
$204M
$3.89M 1.32%
553,652
-12,000
-2% -$95.3K
UHAL icon
17
U-Haul Holding Co
UHAL
$13.9B
$3.86M 1.32%
70,805
-3,959
-5% -$230K
DAR icon
18
Darling Ingredients
DAR
$10B
$3.65M 1.25%
+70,000
New +$4.37M
SIRI icon
19
SiriusXM
SIRI
$10.3B
$2.52M 0.86%
55,784
-10,000
-15% -$465K
NEM icon
20
Newmont
NEM
$95.8B
$2.42M 0.83%
65,600
– –
SUPN icon
21
Supernus Pharmaceuticals
SUPN
$2.79B
$2.26M 0.77%
82,105
– –
ASH icon
22
Ashland
ASH
$3.14B
$1.23M 0.42%
15,000
– –
VICR icon
23
Vicor
VICR
$10.8B
$1.18M 0.4%
+20,000
New +$1.33M
LVTX
24
DELISTED
LAVA Therapeutics
LVTX
$1.15M 0.39%
771,874
– –
IGMS
25
DELISTED
IGM Biosciences
IGMS
$1M 0.34%
120,000
+65,000
+118% +$551K
1
2

Similar funds

RFS
Retirement Financial Solutions Knoxville, Tennessee $350M AUM 16.94% 1-Year Est. Return
WMP
Wealth Management Partners Tucson, Arizona $350M AUM 39.2% 1-Year Est. Return
PCM
Pennsylvania Capital Management Huntingdon Valley, Pennsylvania $349M AUM 20.19% 1-Year Est. Return
SA
SRH Advisors Salina, Kansas $349M AUM 10.46% 1-Year Est. Return
MC
Merck & Co Kenilworth, New Jersey $349M AUM 146.07% 1-Year Est. Return
KFG
Kingdom Financial Group Peoria, Arizona $349M AUM 12.25% 1-Year Est. Return
LAS
Lloyd Advisory Services Suwanee, Georgia $349M AUM 13.97% 1-Year Est. Return
GAA
Global Assets Advisory Orlando, Florida $349M AUM 24.2% 1-Year Est. Return

Bruce & Co's Q3 2023 Portfolio in Review

As of Q3 2023, Bruce & Co held 39 positions worth $293M, down 18% from $356M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

Bruce & Co withdrew a net $55.7M in Q3 2023, closing 1 position and reducing 21 holdings. Its most notable exit was Paratek Pharmaceuticals, Inc., an estimated $3.44M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 34% of assets, down from 36% a quarter earlier, followed by Utilities and Industrials.

Against the trend, Bruce & Co opened a new position in Darling Ingredients worth $3.65M.

  • Bruce & Co's largest Q3 2023 buy was Darling Ingredients: 70,000 shares worth $3.65M.
  • Bruce & Co added most to IGM Biosciences in Q3 2023, an estimated $551K increase.
  • Bruce & Co's biggest Q3 2023 reduction was Merck, cutting an estimated $8.59M.
  • Bruce & Co fully exited Paratek Pharmaceuticals, Inc. in Q3 2023, selling an estimated $3.44M.
  • Bruce & Co's ten largest holdings make up 69% of its $293M portfolio in Q3 2023.
  • Bruce & Co opened 2 new positions and closed 1 in Q3 2023.
  • Bruce & Co's portfolio value fell 18% quarter-over-quarter to $293M.

Based on Bruce & Co's 13F filing for Q3 2023, filed 13 Nov 2023.